Founded in 2001, Chicago-area biotech firm Proteintech set out to create antibodies for scientific research. Back then, explaining what, exactly, an antibody was to investors and the general public wasn’t always easy, CEO Jason Li said. Fast forward 20 years to a world still coping with a global pandemic, and you’d be hard pressed to find someone who hasn’t heard of an antibody.
“After Covid, everyone understands what an antibody is. That’s one job less for us,” Li said.
Proteintech, based…